世界のCOPD薬剤市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV11503)
◆英語タイトル:Global COPD Drugs Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11503
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはCOPD薬剤の世界市場について調査・分析した資料です。種類別(気管支拡張薬、PDE-4阻害薬、ステロイド、併用療法、その他)の市場規模、用途別(病院、クリニック、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別COPD薬剤の競争状況、市場シェア
・世界のCOPD薬剤市場:種類別市場規模 2015年-2020年(気管支拡張薬、PDE-4阻害薬、ステロイド、併用療法、その他)
・世界のCOPD薬剤市場:種類別市場規模予測 2021年-2026年(気管支拡張薬、PDE-4阻害薬、ステロイド、併用療法、その他)
・世界のCOPD薬剤市場:用途別市場規模 2015年-2020年(病院、クリニック、その他)
・世界のCOPD薬剤市場:用途別市場規模予測 2021年-2026年(病院、クリニック、その他)
・北米のCOPD薬剤市場分析:米国、カナダ
・ヨーロッパのCOPD薬剤市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのCOPD薬剤市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のCOPD薬剤市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのCOPD薬剤市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、Novartis、GlaxoSmithKline、Merck、Abbott Laboratories、Boehringer Ingelheim、AstraZeneca、Roche Holding AG、Teva Pharmaceutical Industries、Vectura Group、Mylan NV
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors, steroids, combination therapies, etc.
One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to treat COPD. Combination therapies are increasingly becoming the preferred choice of treatment as they have better efficacy than monotherapy drugs.

Market Analysis and Insights: Global COPD Drugs Market
The global COPD Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global COPD Drugs Scope and Market Size
COPD Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global COPD Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Novartis
GlaxoSmithKline
Merck
Abbott Laboratories
Boehringer Ingelheim
AstraZeneca
Roche Holding AG
Teva Pharmaceutical Industries
Vectura Group
Mylan NV

Market segment by Type, the product can be split into
Bronchodilators
PDE-4 Inhibitors
Steroids
Combination Therapies
Others
Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by COPD Drugs Revenue
1.4 Market by Type
1.4.1 Global COPD Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Bronchodilators
1.4.3 PDE-4 Inhibitors
1.4.4 Steroids
1.4.5 Combination Therapies
1.4.6 Others
1.5 Market by Application
1.5.1 Global COPD Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global COPD Drugs Market Perspective (2015-2026)
2.2 Global COPD Drugs Growth Trends by Regions
2.2.1 COPD Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 COPD Drugs Historic Market Share by Regions (2015-2020)
2.2.3 COPD Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 COPD Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key COPD Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top COPD Drugs Players by Market Size
3.1.1 Global Top COPD Drugs Players by Revenue (2015-2020)
3.1.2 Global COPD Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global COPD Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global COPD Drugs Market Concentration Ratio
3.2.1 Global COPD Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by COPD Drugs Revenue in 2019
3.3 COPD Drugs Key Players Head office and Area Served
3.4 Key Players COPD Drugs Product Solution and Service
3.5 Date of Enter into COPD Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global COPD Drugs Historic Market Size by Type (2015-2020)
4.2 Global COPD Drugs Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global COPD Drugs Market Size by Application (2015-2020)
5.2 Global COPD Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America COPD Drugs Market Size (2015-2020)
6.2 COPD Drugs Key Players in North America (2019-2020)
6.3 North America COPD Drugs Market Size by Type (2015-2020)
6.4 North America COPD Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe COPD Drugs Market Size (2015-2020)
7.2 COPD Drugs Key Players in Europe (2019-2020)
7.3 Europe COPD Drugs Market Size by Type (2015-2020)
7.4 Europe COPD Drugs Market Size by Application (2015-2020)

8 China
8.1 China COPD Drugs Market Size (2015-2020)
8.2 COPD Drugs Key Players in China (2019-2020)
8.3 China COPD Drugs Market Size by Type (2015-2020)
8.4 China COPD Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan COPD Drugs Market Size (2015-2020)
9.2 COPD Drugs Key Players in Japan (2019-2020)
9.3 Japan COPD Drugs Market Size by Type (2015-2020)
9.4 Japan COPD Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia COPD Drugs Market Size (2015-2020)
10.2 COPD Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia COPD Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia COPD Drugs Market Size by Application (2015-2020)

11 India
11.1 India COPD Drugs Market Size (2015-2020)
11.2 COPD Drugs Key Players in India (2019-2020)
11.3 India COPD Drugs Market Size by Type (2015-2020)
11.4 India COPD Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America COPD Drugs Market Size (2015-2020)
12.2 COPD Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America COPD Drugs Market Size by Type (2015-2020)
12.4 Central & South America COPD Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer COPD Drugs Introduction
13.1.4 Pfizer Revenue in COPD Drugs Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis COPD Drugs Introduction
13.2.4 Novartis Revenue in COPD Drugs Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline COPD Drugs Introduction
13.3.4 GlaxoSmithKline Revenue in COPD Drugs Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck COPD Drugs Introduction
13.4.4 Merck Revenue in COPD Drugs Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Details
13.5.2 Abbott Laboratories Business Overview
13.5.3 Abbott Laboratories COPD Drugs Introduction
13.5.4 Abbott Laboratories Revenue in COPD Drugs Business (2015-2020)
13.5.5 Abbott Laboratories Recent Development
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Details
13.6.2 Boehringer Ingelheim Business Overview
13.6.3 Boehringer Ingelheim COPD Drugs Introduction
13.6.4 Boehringer Ingelheim Revenue in COPD Drugs Business (2015-2020)
13.6.5 Boehringer Ingelheim Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca COPD Drugs Introduction
13.7.4 AstraZeneca Revenue in COPD Drugs Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Roche Holding AG
13.8.1 Roche Holding AG Company Details
13.8.2 Roche Holding AG Business Overview
13.8.3 Roche Holding AG COPD Drugs Introduction
13.8.4 Roche Holding AG Revenue in COPD Drugs Business (2015-2020)
13.8.5 Roche Holding AG Recent Development
13.9 Teva Pharmaceutical Industries
13.9.1 Teva Pharmaceutical Industries Company Details
13.9.2 Teva Pharmaceutical Industries Business Overview
13.9.3 Teva Pharmaceutical Industries COPD Drugs Introduction
13.9.4 Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2015-2020)
13.9.5 Teva Pharmaceutical Industries Recent Development
13.10 Vectura Group
13.10.1 Vectura Group Company Details
13.10.2 Vectura Group Business Overview
13.10.3 Vectura Group COPD Drugs Introduction
13.10.4 Vectura Group Revenue in COPD Drugs Business (2015-2020)
13.10.5 Vectura Group Recent Development
13.11 Mylan NV
10.11.1 Mylan NV Company Details
10.11.2 Mylan NV Business Overview
10.11.3 Mylan NV COPD Drugs Introduction
10.11.4 Mylan NV Revenue in COPD Drugs Business (2015-2020)
10.11.5 Mylan NV Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Pfizer、Novartis、GlaxoSmithKline、Merck、Abbott Laboratories、Boehringer Ingelheim、AstraZeneca、Roche Holding AG、Teva Pharmaceutical Industries、Vectura Group、Mylan NV

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のCOPD薬剤市場2026:インサイト・予測(Global COPD Drugs Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。